Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Poly beta amino ester coated emulsions of NSAIDs for cartilage treatment

Saeedi, Tahani and Prokopovich, Polina ORCID: https://orcid.org/0000-0002-5700-9570 2021. Poly beta amino ester coated emulsions of NSAIDs for cartilage treatment. Journal of Materials Chemistry B: Materials for biology and medicine 9 (29) , pp. 5837-5847. 10.1039/D1TB01024G

[thumbnail of Poly beta amino ester coated emulsions of NSAIDs for cartilage treatment.pdf] PDF - Published Version
Available under License Creative Commons Attribution.

Download (6MB)

Abstract

Delivering drugs directly into cartilage is still the major challenge in the management and treatment of osteoarthritis (OA) resulting from the aneural, avascular and alymphatic nature of an articular cartilage structure. Progress has been made in the design of drug delivery systems that enhance corticosteroid uptake and retention in cartilage; however also non-steroidal anti-inflammatory drugs (NSAIDs) are prescribed for patients affected by OA and a drug delivery system specifically designed for this drug category is currently unavailable. We developed an approach based on the preparation of NSAID oil-in-water emulsions coated with poly-beta-amino-esters (PBAEs) to exploit the cartilage penetrating ability of such polymers and the high solubility of drugs in oil. These emulsions containing different NSAIDs (indomethacin, ketorolac, diclofenac and naproxen) exhibited enhanced and prolonged drug localisation not only in healthy cartilage tissues but also in early-stage OA samples. The critical role of the PBAE layer on oil droplets was established along with the retained biological activity of the drug as glycosaminoglycan (GAG) and collagen degradation induced by interleukin-1 (IL-1) was prevented by the novel technology. Oil-in-water coated emulsions are very flexible and cost-effective drug delivery systems and such an approach presented here could provide a substantial improvement in the therapeutic treatments of OA and thus patients’ outcomes.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Pharmacy
Publisher: Royal Society of Chemistry
ISSN: 2050-750X
Funders: Wellcome Trust
Date of First Compliant Deposit: 4 August 2021
Date of Acceptance: 24 June 2021
Last Modified: 05 May 2023 02:53
URI: https://orca.cardiff.ac.uk/id/eprint/143151

Citation Data

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics